XML 52 R41.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS COMBINATIONS - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 28, 2021
Mar. 30, 2021
Mar. 29, 2021
Mar. 03, 2021
Dec. 31, 2020
Aug. 06, 2020
Jan. 03, 2020
Jun. 26, 2021
Jun. 27, 2020
Jun. 26, 2021
Jun. 27, 2020
Dec. 26, 2020
Business Acquisition [Line Items]                        
Goodwill               $ 2,540,067   $ 2,540,067   $ 1,809,168
Vigene Biosciences, Inc.                        
Business Acquisition [Line Items]                        
Integration related costs and transaction costs               2,500   2,500    
Vigene Biosciences, Inc. | Subsequent Event                        
Business Acquisition [Line Items]                        
Purchase price $ 292,500                      
Consideration contingent upon future performance $ 57,500                      
Retrogenix Limited                        
Business Acquisition [Line Items]                        
Purchase price   $ 53,100                    
Consideration contingent upon future performance   6,900                    
Integration related costs and transaction costs               900   1,700    
Cash acquired   8,500                    
Goodwill   33,625                    
Definite-lived intangible assets   $ 22,126                    
Weighted-average amortization life   11 years                    
Property, plant and equipment   $ 400                    
Cognate BioServices, Inc.                        
Business Acquisition [Line Items]                        
Purchase price     $ 876,100                  
Integration related costs and transaction costs               11,200   18,400    
Cash acquired     70,500                  
Value of consideration not acquired     $ 15,700                  
Ownership percentage not acquired     2.00%                  
Revenue from acquiree included in operating results               34,800        
Operating income from acquiree included in operating results               1,100        
Goodwill     $ 603,379                  
Definite-lived intangible assets     $ 266,700                  
Weighted-average amortization life     13 years                  
Property, plant and equipment     $ 52,082                  
Distributed Bio, Inc.                        
Business Acquisition [Line Items]                        
Purchase price         $ 97,000              
Consideration contingent upon future performance         21,000              
Integration related costs and transaction costs               200   900    
Cash acquired         800              
Cash portion of consideration transferred         80,800              
Payments to settle promissory note         3,000              
Contingent consideration liability         14,000              
Goodwill         71,585              
Definite-lived intangible assets         $ 24,540              
Weighted-average amortization life         7 years              
Property, plant and equipment         $ 2,382              
Cellero, LLC                        
Business Acquisition [Line Items]                        
Purchase price           $ 36,900            
Integration related costs and transaction costs               200   600    
Cash acquired           500            
Goodwill, amount expected to be deductible for tax purposes           10,800            
Goodwill           19,457            
Definite-lived intangible assets           $ 16,230            
Weighted-average amortization life           12 years            
Property, plant and equipment           $ 1,648            
HemaCare Corporation                        
Business Acquisition [Line Items]                        
Purchase price             $ 376,700          
Integration related costs and transaction costs               $ 300 $ 100 400 $ 5,800  
Cash acquired             3,100          
Goodwill             210,196          
Definite-lived intangible assets             $ 183,540          
Weighted-average amortization life             18 years          
Property, plant and equipment             $ 10,033          
Other Acquisitions                        
Business Acquisition [Line Items]                        
Purchase price       $ 35,400                
Consideration contingent upon future performance       17,500                
Cash portion of consideration transferred       19,500               $ 5,500
Contingent consideration liability       $ 15,900                
Future performance period       3 years                
Goodwill       $ 17,300                
Definite-lived intangible assets       15,200                
Property, plant and equipment       $ 3,000                
Other Acquisitions | Supplier Relationships                        
Business Acquisition [Line Items]                        
Weighted-average amortization life       4 years                
Depreciation and Amortization Expense | Cognate BioServices, Inc.                        
Business Acquisition [Line Items]                        
Adjustments related to prior period                   9,500 10,200  
Depreciation and Amortization Expense | HemaCare Corporation                        
Business Acquisition [Line Items]                        
Adjustments related to prior period                     400  
Interest Expense | Cognate BioServices, Inc.                        
Business Acquisition [Line Items]                        
Adjustments related to prior period                   $ 2,200 $ 4,100